Enterobiotix

Enterobiotix company information, Employees & Contact Information

Explore related pages

Related company profiles:

EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome.

Company Details

Employees
54
Founded
-
Email
in****@****tix.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Oxford.
Looking for a particular Enterobiotix employee's phone or email?

Enterobiotix Questions

News

EBX-102-02, A Full-Spectrum Microbiome Drug, Shows Promise for IBS-C in Phase 2a Trial - HCPLive

EBX-102-02, A Full-Spectrum Microbiome Drug, Shows Promise for IBS-C in Phase 2a Trial HCPLive

EnteroBiotix cues up larger trial of microbiome IBS therapy - pharmaphorum

EnteroBiotix cues up larger trial of microbiome IBS therapy pharmaphorum

EnteroBiotix secures $21.5M series A to advance microbiome drug pipeline - Fierce Biotech

EnteroBiotix secures $21.5M series A to advance microbiome drug pipeline Fierce Biotech

License granted to EnteroBiotix for manufacture of microbiome product candidates - Labiotech.eu

License granted to EnteroBiotix for manufacture of microbiome product candidates Labiotech.eu

Microbiome IBS Treatment Scores at Phase II - Inside Precision Medicine

Microbiome IBS Treatment Scores at Phase II Inside Precision Medicine

EnteroBiotix Secures £2m Seed Extension Investment - BioSpace

EnteroBiotix Secures £2m Seed Extension Investment BioSpace

Enterobiotix adds $21.5M series A for microbial therapies - BioWorld MedTech

Enterobiotix adds $21.5M series A for microbial therapies BioWorld MedTech

Imperial partnering with EnteroBiotix to advance microbiome medical treatments - Imperial College London

Imperial partnering with EnteroBiotix to advance microbiome medical treatments Imperial College London

Bank commits £6 million to EnteroBiotix’s £27 million funding round - Scottish Financial News

Bank commits £6 million to EnteroBiotix’s £27 million funding round Scottish Financial News

Gut health company closes largest-ever funding round - The Herald

Gut health company closes largest-ever funding round The Herald

Scottish biotech firm EnteroBiotix announces new executive chairman - insider.co.uk

Scottish biotech firm EnteroBiotix announces new executive chairman insider.co.uk

EnteroBiotix hires new COO and CFO - insider.co.uk

EnteroBiotix hires new COO and CFO insider.co.uk

Gut health firm EnteroBiotix secures £27m funding - insider.co.uk

Gut health firm EnteroBiotix secures £27m funding insider.co.uk

EnteroBiotix partners Imperial College London for microbiome research - insider.co.uk

EnteroBiotix partners Imperial College London for microbiome research insider.co.uk

Biopharm start-up EnteroBiotix appoints new CEO as it is granted MHRA licence - insider.co.uk

Biopharm start-up EnteroBiotix appoints new CEO as it is granted MHRA licence insider.co.uk

Top Enterobiotix Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant